Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269950 | HPB | 2007 | 8 Pages |
Abstract
Pancreatic carcinoma accounts for the most dismal survival among all malignancies with 5-year survival rates approaching 5%. The reason for this, besides the inherent biologic nature of the disease, is the fact that the patients tend to present late in the disease. We present a review of the current published data on cystic neoplasms of the pancreas, which though rare, constitute an important subgroup of pancreatic neoplasms that have a better prognosis and are potentially curable lesions.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
George Barreto, Parul J. Shukla, Mukta Ramadwar, Supreeta Arya, Shailesh V. Shrikhande,